| [1] |
中华医学会内分泌学分会免疫内分泌学组. 免疫检查点抑制剂引起的内分泌系统免疫相关不良反应专家共识(2020)[J]. 中华内分泌代谢杂志, 2021, 37(1):1-16.
|
|
Immune-endocrinology Group, Chinese Society of Endocrinology, Chinese Medical Association. Chinese expert consensus on the immune checkpoint inhibitors-induced endocrine immune-related adverse events(2020)[J]. Chin J Endocrinol Metab, 2021, 37(1):1-16.
|
| [2] |
Liu JQ, Zhou HQ, Zhang YX, et al. Reporting of immune checkpoint inhibitor therapy-associated diabetes,2015-2019[J]. Diabetes Care, 2020, 43(7):e79-e80.
DOI
URL
|
| [3] |
杨中策, 董林涛, 潘俐, 等. 中国暴发1型糖尿病患者临床特点的Meta分析[J]. 中国循证医学杂志, 2022, 22(8):891-895.
|
|
Yang ZC, Dong LT, Pan L, et al. Clinical characteristics of Chinese patients with fulminant type 1 diabetes mellitus:a meta-analysis[J]. Chin J Evid Based Med, 2022, 22(8):891-895.
|
| [4] |
Imagawa A. Two types of fulminant type 1 diabetes mellitus:immune checkpoint inhibitor-related and conventional[J]. J Diabetes Investig, 2021, 12(6):917-919.
DOI
URL
|
| [5] |
邱俊霖, 罗说明, 殷文凤, 等. PD-1相关性暴发性1型糖尿病的临床与免疫特征[J]. 中南大学学报(医学版), 2023, 48(1):49-58.
|
|
Qiu JL, Luo SM, Yin WF, et al. Clinical and immunological characteristics of PD-1 associated fulminant type 1 diabetes mellitus[J]. J Central South Univ Med Sci, 2023, 48(1):49-58.
|
| [6] |
杨稳, 严健如, 罗泰宏, 等. 抗PD-1治疗诱导暴发性1型糖尿病一例报道[J]. 中国糖尿病杂志, 2022, 30(10):783-785.
|
|
Yang W, Yan JR, Luo TH, et al. Fulminant type 1 diabetes mellitus induced by programmed cell death protein 1 inhibitor:a case report[J]. Chin J Diabetes, 2022, 30(10):783-785.
|
| [7] |
中华医学会糖尿病学分会, 中国医师协会内分泌代谢科医师分会, 中华医学会内分泌学分会, 等. 中国1型糖尿病诊治指南(2021版)[J]. 中华糖尿病杂志, 2022, 14(11):1143-1250.
|
|
Chinese Diabetes Society,Chinese Endocrinologist Association,Chinese Endocrinology Association, et al. Guidelines for the diagnosis and treatment of type 1 diabetes mellitus in China(2021 edition)[J]. Chin J Diabetes Mellit, 2022, 14(11):1143-1250.
|
| [8] |
Clotman K, Janssens K, Specenier P, et al. Programmed cell death-1 inhibitor-induced type 1 diabetes mellitus[J]. J Clin Endocrinol Metab, 2018, 103(9):3144-3154.
DOI
PMID
|
| [9] |
费超男, 段培蓓, 杨玲, 等. 胃癌患者围手术期营养管理的最佳证据总结[J]. 中华护理杂志, 2022, 57(19):2345-2352.
DOI
URL
|
|
Fei CN, Duan PB, Yang L, et al. Evidence summary of nutri-tional management in patients with gastric cancer during the perioperative period[J]. Chin J Nurs, 2022, 57(19):2345-2352.
|
| [10] |
中国医疗保健国际交流促进会营养与代谢管理分会, 中国营养学会临床营养分会, 中华医学会糖尿病学分会, 等. 中国糖尿病医学营养治疗指南(2022版)[J]. 中华糖尿病杂志, 2022, 14(9):881-933.
|
|
Nutrition and Metabolic Management Branch, China Healthcare International Exchange Promotion Associatione, Clinical Nutrition Branch of the Chinese Nutrition Society, et al. Chinese guidelines of medical nutrition therapy in diabetes(2022 edition)[J]. Chin J Diabetes Mellit, 2022, 14(9):881-933.
|
), 曾莉容(